Mizuho Financial Stock Price, News & Analysis

Mizuho Americas has appointed Nitin Kumar as Managing Director and Senior Energy Equity Research Analyst, leading the U.S. Oil and Gas equity research team. His experience includes roles at Wells Fargo and Deutsche Bank. Kumar's hiring comes at a crucial time for the energy sector, marked by volatility and a focus on sustainable energy. His insights aim to bolster Mizuho's expertise in a sector experiencing heightened investor interest. The company, part of the Mizuho Financial Group (NYSE: MFG), is a major player in global financial services.

Mizuho Americas has appointed Joseph O’Doherty as Managing Director and Head of Residential Mortgage Finance. O'Doherty will launch and lead the Mortgage Finance business, which includes Agency and Non-Agency Mortgage products, and will collaborate with Mizuho’s MBS Trading and Sales teams. He joins Mizuho after nearly 20 years at Barclays and possesses a strong background in securitized products. This strategic addition aims to enhance Mizuho’s market offerings and capitalize on its robust financial position.

The inaugural Mizuho Americas Open will take place from May 29 to June 4, 2023, at Liberty National Golf Club in Jersey City, NJ. This LPGA event features a purse of $2.75 million, one of the largest for the tour. It uniquely combines professional players with 24 junior golfers from the AJGA in a groundbreaking format. Former LPGA star Michelle Wie West will serve as Tournament Host and Brand Ambassador. This partnership aims to promote women in sports and nurture future talent, marking Mizuho's first U.S. sports sponsorship.

Mizuho Americas has appointed David Moore as Managing Director and Head of Macro Trading, overseeing secured financing, rates cash and derivatives, and foreign exchange. Reporting to Thomas Hartnett, this addition aims to enhance the firm's trading capabilities and product offerings. Moore brings extensive experience from his previous roles at Morgan Stanley, Bank of America, and BNP Paribas. His leadership is expected to drive growth in Mizuho's diverse client segments and strengthen its position in the macro trading market.

Mizuho Financial Group, Inc. has filed its annual report on Form 20-F with the U.S. Securities and Exchange Commission on July 1, 2022. The report is available online for investors and stakeholders. Shareholders holding American Depository Receipts can request a complimentary hard copy of the audited financial statements via email. This announcement serves purely for informational purposes and does not constitute an investment offer within or outside Japan.

Mizuho Americas has successfully completed its acquisition of Capstone Partners, enhancing its investment banking services for financial sponsors in the alternative investment sector. This strategic move is expected to strengthen Mizuho’s capital raising and advisory capabilities, as highlighted by CEO Jerry Rizzieri. Capstone, recognized as the 2021 'Best Placement Agent' by Private Equity Wire, possesses a vast network with over 1,500 Limited Partners globally. This acquisition aligns with Mizuho’s ongoing expansion in investment banking, aiming for greater market opportunities and increased capital flows.

Mizuho Americas has appointed Dominic Konstam as Managing Director and Head of Macro Strategy within its Interest Rate Products business. With 30 years of experience in financial services, Konstam joins from Citibank, having also held senior roles at Deutsche Bank and Credit Suisse. This new role aims to enhance client engagement by integrating market insights with the firm’s economic analysis. Mizuho Americas is part of the global Mizuho Financial Group, which has approximately $2 trillion in total assets.

Mizuho Americas announces the hiring of Anthony Petrone as Managing Director, Senior Medical Devices, Diagnostics and Therapeutics Equity Research Analyst, effective March 1, 2022. Reporting to Susan Gilbertson, Petrone brings over 16 years of healthcare research experience from Jefferies. His expertise will enhance Mizuho's global healthcare services amidst significant growth in testing and diagnostics due to COVID-19. Petrone holds degrees from Pace University and Columbia University, marking a strategic move for Mizuho in the healthcare sector.

Mizuho Americas has appointed Graig Suvannavejh, PhD, as Managing Director and Senior Analyst in Biopharmaceuticals and Biotechnology Equity Research. Suvannavejh brings over 20 years of healthcare industry experience, including leadership roles in biotechnology research at Goldman Sachs. He will work alongside a well-established team and report to Susan Gilbertson, Head of US Equity Research. Mizuho Americas aims to enhance its financial services in the healthcare sector through Suvannavejh's expertise, which combines sell-side research with operational insights.